CTKB logo

Cytek Biosciences (CTKB)

Profile

Full Name

Cytek Biosciences, Inc.

Ticker Symbol

CTKB

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

July 23, 2021

Indexes

Not included

Website

http://cytekbio.com

Employees

663

Key Details

Price

$3.60(-0.14%)

Market cap

$456.61M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$200.45M(+3.85% YoY)

Annual EPS

-$0.05(+44.44% YoY)

PE ratio

-

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.60
    CTKB price is $3.60

    30-Day Relative Volume

    1.14
    CTKB 30-day relative volume is 1.14

    Price Performance

    Price Today change

    -0.14%
    CTKB price is down -0.14% today

    Price YTD change

    -44.45%
    CTKB price is down -44.45% since January 1st

    Price 1-year change

    -35.28%
    CTKB price is down -35.28% year-on-year

    Price 3-year change

    -67.11%
    CTKB price is down -67.11% over the past 3 years

    Price Range

    Price All-time high

    $28.70
    CTKB price is currently -87.44% below its historical high of $28.70

    Price 3-year low

    $2.37
    CTKB price is currently +52.11% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $456.61M
    CTKB market capitalization is $456.61 million

    Market cap 3-year change

    -69.05%
    CTKB market capitalization is down -69.05% over the past 3 years

    Market cap All-time high

    $3.73B
    CTKB market capitalization is currently -87.77% below its historical high of $3.73 billion

    Market cap sector rank

    65.47%
    CTKB market capitalization is higher than 65.47% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -3.69%
    CTKB shares outstanding is down -3.69% year-on-year

    Shares Outstanding 3-Year Change

    -5.9%
    CTKB shares outstanding is down -5.9% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.27
    CTKB beta is 1.27

    200-day SMA

    $4.84
    CTKB price is currently -25.54% below its 200-day simple moving average

    50-day SMA

    $3.24
    CTKB price is currently +11.38% above its 50-day simple moving average

    RSI

    60.81
    CTKB 14-day relative strength index is 60.81

    Volume

    1.14
    CTKB 30-day relative volume is 1.14

    ATR

    $0.22
    CTKB average true range is $0.22

    10-day Historical Volatility

    64.45%
    CTKB 10-day historical volatility is 64.45%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $200.45M
    CTKB annual revenue is $200.45 million

    Revenue Analysts estimate

    $198.30M
    CTKB annual revenue is currently +1.09% higher than the consensus analysts' forecast

    Revenue 1-year change

    +3.85%
    CTKB annual revenue is up +3.85% year-on-year

    Revenue Sector rank

    64.29%
    CTKB annual revenue is higher than 64.29% of companies in Healthcare sector

    EPS

    EPS

    -$0.05
    CTKB annual earnings per share is -$0.05

    EPS Analysts estimate

    -$0.01
    CTKB annual earnings per share is currently +900.00% higher than the consensus analysts' forecast

    EPS 1-year change

    +44.44%
    CTKB annual earnings per share is up +44.44% year-on-year

    EPS Sector rank

    80.56%
    CTKB annual earnings per share is higher than 80.56% of companies in Healthcare sector

    Profit

    Gross profit

    $111.11M
    CTKB annual gross profit is $111.11 million

    Gross margin

    55.43%
    CTKB annual gross profit margin is 55.43%

    Operating profit

    -$20.52M
    CTKB annual operating income is -$20.52 million

    Operating margin

    -10.24%
    CTKB annual operating profit margin is -10.24%

    Net income

    -$6.02M
    CTKB annual net profit is -$6.02 million

    Net margin

    -3.00%
    CTKB annual net profit margin is -3.00%

    Expenses

    Total expenses

    $220.98M
    CTKB annual total expenses is $220.98 million

    Operating expenses

    $131.63M
    CTKB annual total operating expenses is $131.63 million

    Cost of goods sold

    $89.35M
    CTKB annual cost of goods sold is $89.35 million

    Selling, general & administrative expenses

    $92.23M
    CTKB annual SGA is $92.23 million

    Depreciation and amortization

    $10.49M
    CTKB annual depreciation & amortization is $10.49 million

    Interest expense

    -
    CTKB annual interest expense value is unknown

    Income tax

    $320.00K
    CTKB annual income tax is $320.00 thousand

    EBIT & EBITDA

    EBIT

    -$20.52M
    CTKB annual earnings before interest & taxes is -$20.52 million

    EBITDA

    -$10.03M
    CTKB annual EBITDA is -$10.03 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $499.50M
    CTKB annual total assets is $499.50 million

    Non current assets

    $103.05M
    CTKB annual long term assets is $103.05 million

    Current assets

    $396.45M
    CTKB annual total current assets is $396.45 million

    Cash and cash equivalents

    $98.72M
    CTKB annual cash & cash equivalents is $98.72 million

    Accounts receivable

    $60.59M
    CTKB annual accounts receivable is $60.59 million

    Inventory

    $43.89M
    CTKB annual inventory is $43.89 million

    Liabilities

    Total liabilities

    $103.76M
    CTKB annual total liabilities is $103.76 million

    Long term liabilities

    $36.10M
    CTKB annual total long term liabilities is $36.10 million

    Current liabilities

    $67.66M
    CTKB annual total current liabilities is $67.66 million

    Accounts payable

    $5.53M
    CTKB annual accounts payable is $5.53 million

    Debt

    Total debt

    $17.02M
    CTKB annual total debt is $17.02 million

    Total debt 1-year change

    +20.37%
    CTKB annual total debt is up +20.37% year-on-year

    Long term debt

    $8.60M
    CTKB annual long term debt is $8.60 million

    Short term debt

    $8.41M
    CTKB annual short term debt is $8.41 million

    Equity & Capital

    Shareholders equity

    $395.74M
    CTKB annual stockholders equity is $395.74 million

    Book value

    $395.74M
    CTKB annual book value is $395.74 million

    Retained earnings

    -$35.20M
    CTKB annual retained earnings is -$35.20 million

    Working capital

    $328.78M
    CTKB annual working capital is $328.78 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $25.38M
    CTKB annual cash flow from operations is $25.38 million

    Cash from operations 1-year change

    +380.57%
    CTKB annual cash flow from operations is up +380.57% year-on-year

    Cash from investing

    -$82.97M
    CTKB annual cash flow from investing activities is -$82.97 million

    Cash from investing 1-year change

    +11.63%
    CTKB annual cash flow from investing activities is up +11.63% year-on-year

    Cash from financing

    -$15.82M
    CTKB annual cash flow from financing activities is -$15.82 million

    Cash from financing 1-year change

    +62.16%
    CTKB annual cash flow from financing activities is up +62.16% year-on-year

    CAPEX

    CAPEX

    $3.73M
    CTKB annual capital expenditures is $3.73 million

    CAPEX 1-year change

    -22.75%
    CTKB annual capital expenditures is down -22.75% year-on-year

    Free Cash Flow

    Free cash flow

    $21.65M
    CTKB annual free cash flow is $21.65 million

    Free cash flow 1-year change

    +4668.72%
    CTKB annual free cash flow is up +4668.72% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    55.43%
    CTKB annual gross profit margin is 55.43%

    Operating margin

    -10.24%
    CTKB annual operating profit margin is -10.24%

    Net margin

    -3.00%
    CTKB annual net profit margin is -3.00%

    ROA & ROE

    ROA

    -1.21%
    CTKB annual return on assets is -1.21%

    ROE

    -1.53%
    CTKB annual return on equity is -1.53%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CTKB price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CTKB price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.20
    CTKB price to book ratio is 1.20

    PB ratio Sector rank

    43.82%
    CTKB price to book ratio is higher than 43.82% of companies in Healthcare sector

    PS Ratio

    PS ratio

    2.32
    CTKB price to sales ratio is 2.32

    PS ratio Sector rank

    43.52%
    CTKB price to sales ratio is higher than 43.52% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $377.21M
    CTKB enterprise value is $377.21 million

    Enterprise value Sector rank

    62.46%
    CTKB enterprise value is higher than 62.46% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -31.35
    CTKB EV/EBITDA is -31.35

    EV/EBITDA Sector rank

    5.57%
    CTKB EV/EBITDA is higher than 5.57% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    5.86
    CTKB annual current ratio is 5.86

    Quick ratio

    5.21
    CTKB annual quick ratio is 5.21

    Leverage

    Debt to equity

    0.01
    CTKB annual debt to equity ratio is 0.01

    Interest coverage ratio

    -
    CTKB annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    4
    CTKB piotroski f-score is 4

    Altman Z-Score

    3.60
    CTKB altman z-score is 3.60

    Analyst ratings

    Recent major analysts updates

    May 28, 25 Morgan Stanley
    Equal-Weight
    May 12, 25 Goldman Sachs
    Sell
    Mar 19, 25 Stephens & Co.
    Overweight
    Mar 4, 25 Piper Sandler
    Overweight
    Nov 11, 24 Piper Sandler
    Overweight
    Aug 13, 24 Piper Sandler
    Overweight
    May 13, 24 Piper Sandler
    Overweight
    Mar 6, 24 Piper Sandler
    Overweight
    Feb 29, 24 Goldman Sachs
    Buy
    Dec 14, 23 Stephens & Co.
    Overweight

    Institutional Ownership

    Screeners with CTKB included

    US stocks
    Stocks with high beta
    Best performing stocks last month
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for Cytek Biosciences?
    • Does Cytek Biosciences pay dividends?
    • What sector is Cytek Biosciences in?
    • What industry is Cytek Biosciences in?
    • What country is Cytek Biosciences based in?
    • When did Cytek Biosciences go public?
    • Is Cytek Biosciences in the S&P 500?
    • Is Cytek Biosciences in the NASDAQ 100?
    • Is Cytek Biosciences in the Dow Jones?
    • When was Cytek Biosciences's last earnings report?
    • When does Cytek Biosciences report earnings?
    • Should I buy Cytek Biosciences stock now?

    What is the ticker symbol for Cytek Biosciences?

    The ticker symbol for Cytek Biosciences is NASDAQ:CTKB

    Does Cytek Biosciences pay dividends?

    No, Cytek Biosciences does not pay dividends

    What sector is Cytek Biosciences in?

    Cytek Biosciences is in the Healthcare sector

    What industry is Cytek Biosciences in?

    Cytek Biosciences is in the Medical Devices industry

    What country is Cytek Biosciences based in?

    Cytek Biosciences is headquartered in United States

    When did Cytek Biosciences go public?

    Cytek Biosciences's initial public offering (IPO) was on July 23, 2021

    Is Cytek Biosciences in the S&P 500?

    No, Cytek Biosciences is not included in the S&P 500 index

    Is Cytek Biosciences in the NASDAQ 100?

    No, Cytek Biosciences is not included in the NASDAQ 100 index

    Is Cytek Biosciences in the Dow Jones?

    No, Cytek Biosciences is not included in the Dow Jones index

    When was Cytek Biosciences's last earnings report?

    Cytek Biosciences's most recent earnings report was on May 8, 2025

    When does Cytek Biosciences report earnings?

    The next expected earnings date for Cytek Biosciences is Aug 6, 2025

    Should I buy Cytek Biosciences stock now?

    As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page